09:58 AM EST - Aeterna Zentaris Inc. : Announced that the abstract on study results of its first pediatric study on macimorelin has been selected for presentation at the 22nd European Congress of Endocrinology (e-ECE 2020) being held September 5-9. Aeterna Zentaris Inc.
shares T.AEZS are trading unchanged at $0.62.
